| 标题 |
Lenvatinib plus transarterial chemoembolization and PD-1 inhibitors as conversion therapies for unresectable intermediate-advanced hepatocellular carcinoma: a phase 2 trial and exploratory biomolecular study |
| 网址 | |
| DOI | |
| 其它 | PMID:41565617 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)